Literature DB >> 21344151

Chikungunya virus isolates with/without A226V mutation show different sensitivity to IFN-a, but similar replication kinetics in non human primate cells.

Licia Bordi1, Silvia Meschi, Marina Selleri, Eleonora Lalle, Concetta Castilletti, Fabrizio Carletti, Roberta Chiappini, Antonino Di Caro, Maria Rosaria Capobianchi.   

Abstract

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus responsible for the first autochthonous Italian outbreak in 2007. A226V mutation in E1 has been associated with enhanced replication in A. albopictus vector. Possible involvement of this mutation in enhanced infection capability in primate cells and sensitivity to exogenous interferon (IFN)-a was investigated. No significant differences were observed between the two isolates in terms of replication kinetic, virus yield and cytopathic effect (CPE). Interestingly, the A226V-carrying strain was more susceptible to the antiviral action of recombinant IFN-a. The interplay between A226V mutation and innate defence mechanisms needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21344151

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  9 in total

1.  Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells.

Authors:  Tabitha E Hoornweg; Mareike K S van Duijl-Richter; Nilda V Ayala Nuñez; Irina C Albulescu; Martijn J van Hemert; Jolanda M Smit
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

2.  Structural basis for complementary and alternative medicine: Phytochemical interaction with non-structural protein 2 protease-a reverse engineering strategy.

Authors:  G Koushik Kumar; G Prasanna; T Marimuthu; N T Saraswathi
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

3.  Bridging the Gap Between Experimental Data and Model Parameterization for Chikungunya Virus Transmission Predictions.

Authors:  Rebecca C Christofferson; Christopher N Mores; Helen J Wearing
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

4.  Identification of Natural Molecular Determinants of Ross River Virus Type I Interferon Modulation.

Authors:  Adam Taylor; Suresh Mahalingam; Xiang Liu; Margit Mutso; Liubov Cherkashchenko; Eva Zusinaite; Lara J Herrero; Stephen L Doggett; John Haniotis; Andres Merits; Belinda L Herring
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

Review 5.  Towards antivirals against chikungunya virus.

Authors:  Rana Abdelnabi; Johan Neyts; Leen Delang
Journal:  Antiviral Res       Date:  2015-06-25       Impact factor: 5.970

Review 6.  The origin and continuing adaptive evolution of chikungunya virus.

Authors:  Mohamad S Hakim; Luthvia Annisa; Faris M Gazali; Abu T Aman
Journal:  Arch Virol       Date:  2022-08-20       Impact factor: 2.685

7.  Antiviral Strategies Against Chikungunya Virus.

Authors:  Rana Abdelnabi; Johan Neyts; Leen Delang
Journal:  Methods Mol Biol       Date:  2016

8.  Full-Length Genome Sequence of a Chikungunya Virus Isolate from the 2017 Autochthonous Outbreak, Lazio Region, Italy.

Authors:  Fabrizio Carletti; Patrizia Marsella; Francesca Colavita; Silvia Meschi; Eleonora Lalle; Licia Bordi; Domenico Di Lallo; Vincenzo Panella; Antonino Di Caro; Emanuele Nicastri; Paola Scognamiglio; Simone Lanini; Francesco Vairo; Maria R Capobianchi; Giuseppe Ippolito; Concetta Castilletti
Journal:  Genome Announc       Date:  2017-12-07

Review 9.  Chikungunya virus: an update on antiviral development and challenges.

Authors:  Parveen Kaur; Justin Jang Hann Chu
Journal:  Drug Discov Today       Date:  2013-05-15       Impact factor: 7.851

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.